During the past decade, UPMC Cancer Center at UPMC Presbyterian conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Cancer Center at UPMC Presbyterian" #1 sponsor was "Radiation Therapy Oncology Group" with 5 trials, followed by "University of Pittsburgh" with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "Duke University" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Cancer Center at UPMC Presbyterian" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Cancer Center at UPMC Presbyterian" are "Prostate Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Breast Cancer" (2 trials), "Metastatic Cancer" (2 trials) and "Pain" (2 trials). Many other conditions were trialed in "UPMC Cancer Center at UPMC Presbyterian" in a lesser frequency.

Most popular intervention types in "UPMC Cancer Center at UPMC Presbyterian" are "Drug" (10 trials), "Radiation" (7 trials), "Procedure" (3 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "LHRH agonist" (2 trials), "adjuvant therapy" (2 trials), "radiation therapy" (2 trials), "AA" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Cancer Center at UPMC Presbyterian" are 11 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "UPMC Cancer Center at UPMC Presbyterian". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in UPMC Cancer Center at UPMC Presbyterian, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Cancer Center at UPMC Presbyterian, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".